𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer

✍ Scribed by Meyers, D A; Isaacs, W B; Chang, B L; Zheng, S L; Isaacs, S D; Turner, A; Hawkins, G A; Wiley, K E; Bleecker, E R; Walsh, P C

Book ID
109997771
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
98 KB
Volume
89
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Polymorphisms in the CYP1A1 gene are ass
Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk
✍ Bao-li Chang; Siqun L. Zheng; Sarah D. Isaacs; Aubrey Turner; Gregory A. Hawkins πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 72 KB πŸ‘ 2 views

## Abstract CYP1A1 is likely to play an important role in the etiology of CaP through its function in activating environmental procarcinogens and catalyzing the oxidative metabolites of estrogens. To test the hypothesis that genetic polymorphisms in the __CYP1A1__ gene may be associated with the ri

A polymorphism in the CYP17 gene is asso
A polymorphism in the CYP17 gene is associated with prostate cancer risk
✍ Andrea Gsur; Gabriele Bernhofer; Sonja Hinteregger; Gerald Haidinger; Georg Scha πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 63 KB πŸ‘ 2 views

CYP17 encodes the enzyme cytochrome P-450c17␣, which mediates both 17␣-hydroxylase and 17,20-lyase in the steroid biosynthesis pathway. A polymorphism in the 5 promoter region of the CYP17 gene has been described. Steroid hormones, especially androgens, are believed to play a key role in the etiolog

Polymorphisms of the interleukin-1 Ξ² gen
Polymorphisms of the interleukin-1 Ξ² gene are associated with increased risk of non-small cell lung cancer
✍ Shanbeh Zienolddiny; David Ryberg; Valentina Maggini; Vidar Skaug; Federico Canz πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 78 KB πŸ‘ 1 views

## Abstract Lung cancer is one of the leading causes of cancer death worldwide. Tobacco smoking is the main risk factor for lung cancer. Less than 20% of smokers develop lung cancer in their lifetime, however, indicating individual variations in lung cancer risk. Pro‐inflammatory cytokines produced